HomePharma

Pharma

Elacestrant Unveiled: A New Horizon for Hormone-Driven Breast Cancer

Patients with a type of breast cancer that grows in response to estrogen (ER-positive) but does not have the HER2 protein (HER2-negative) often start...

Atossa Therapeutics Hits Milestone in Breast Cancer Trial with Full Enrollment

Atossa Therapeutics Inc has recently made an announcement about progress in one of its breast cancer studies. They've completed enrolling participants for a specific...

BriaCell Reveals Notable Results in Breast Cancer Treatment Trials

BriaCell Therapeutics Corp., a biotech firm focused on developing new treatments for cancer, recently shared promising results from their studies on breast cancer treatments....

Hot Topics